Citation Impact

Citing Papers

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
2013
Inadequate erythropoietin response to anemia: definition and clinical relevance
1994
Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital
2008
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Platelet density in essential thrombocythemia and polycythemia vera
1999
Long‐term follow‐up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome
2006
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
2006
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS
2001
Myelodysplastic Syndromes
2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
2004
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes
2004
Targeting multidrug resistance in cancer
2006 Standout
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists
2011
The use of platelet density and volume measurements to estimate the severity of pre‐eclampsia
2000 StandoutNobel
Identification of low-density platelet populations with increased reactivity and elevated α-granule content
2003 StandoutNobel
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis
2005
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Early allogeneic transplantation for refractory or relapsed acute leukaemia following remission induction with FLAG
1999
Platelet Density Distribution in Essential Thrombocythemia
2010 StandoutNobel
Inverse Relationship between Platelet Density and Reactivity Alterations at Coronary Angiography
2001 StandoutNobel
Anemia of Chronic Disease
2005 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Acute Myeloid Leukemia
2015 Standout
On Radiation Damage to Normal Tissues and its Treatment: II. Anti-inflammatory drugs
1994
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout

Works of R. Grace being referenced

Changes in serum erythropoietin levels during allogeneic bone marrow transplantation
1991
Venesection in Haemoglobin Yakima, a high oxygen affinity haemoglobin
2008
Primary thrombocythaemia: a composite approach to diagnosis
2008
Fludarabine, cytarabine, G‐CSF and idarubicin (FLAG‐IDA) for the treatment of poor‐risk myelodysplastic syndromes and acute myeloid leukaemia
1997
Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy
2007
Rankless by CCL
2026